tirzepatide patents As Novo's patent expires, GLP-1 generics go global mounjaro tirzepatide patent expiration mounjaro

Klein S, Gastaldelli A, Yki-Jrvinen H, Scherer PE

Both drugs are in the India GLP-1 receptor agonist market , which was valued at approximately USD 150.8 million in 2025 and is projected to grow at a compound annual growth rate of 22.7% through 2033 , driven by rising prevalence of type 2 diabetes and increasing clinical adoption of incretin-based therapies

I think I'll stop taking Retatrutide: my focus is slightly better, but my resting heart rate is close to 15 bpm higher than when I started, I would prefer to not sweat as much or have my heart rate spike as high during exercise

Both smoking and meloxicam can irritate the stomach lining, so combining them increases the chances of serious stomach or intestinal problems

26, 2025 (GLOBE NEWSWIRE) -- The term "best" reflects common consumer search phrasing and is used here to compare access pathways, not to endorse or rank any product or provider